Literature DB >> 24333308

Clinical use of albumin.

Paolo Caraceni1, Manuel Tufoni1, Maria Elena Bonavita1.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24333308      PMCID： PMC3853979          DOI： 10.2450/2013.005s

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  59 in total

1.  Intravenous albumin in the treatment of diuretic-resistant ascites in portal cirrhosis.

Authors:  M S LOSOWSKY; M ATKINSON
Journal:  Lancet       Date:  1961-08-19       Impact factor: 79.321

Review 2.  EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.

Authors: 
Journal:  J Hepatol       Date:  2010-06-01       Impact factor: 25.083

3.  Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis.

Authors:  Simon Finfer; Suzanne McEvoy; Rinaldo Bellomo; Colin McArthur; John Myburgh; Robyn Norton
Journal:  Intensive Care Med       Date:  2010-10-06       Impact factor: 17.440

4.  Recommendations for the use of albumin and immunoglobulins.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossettias
Journal:  Blood Transfus       Date:  2009-07       Impact factor: 3.443

5.  Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.

Authors:  Rafael Bañares; Frederik Nevens; Fin Stolze Larsen; Rajiv Jalan; Agustín Albillos; Matthias Dollinger; Faouzi Saliba; Tilman Sauerbruch; Sebastian Klammt; Johann Ockenga; Albert Pares; Julia Wendon; Tanja Brünnler; Ludwig Kramer; Philippe Mathurin; Manuel de la Mata; Antonio Gasbarrini; Beat Müllhaupt; Alexander Wilmer; Wim Laleman; Martin Eefsen; Sambit Sen; Alexander Zipprich; Teresa Tenorio; Marco Pavesi; Hartmut H-J Schmidt; Steffen Mitzner; Roger Williams; Vicente Arroyo
Journal:  Hepatology       Date:  2013-02-15       Impact factor: 17.425

6.  How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure.

Authors:  Federica Mirici-Cappa; Paolo Caraceni; Marco Domenicali; Ernesto Gelonesi; Barbara Benazzi; Giacomo Zaccherini; Franco Trevisani; Cristina Puggioli; Mauro Bernardi
Journal:  World J Gastroenterol       Date:  2011-08-14       Impact factor: 5.742

Review 7.  Terlipressin for hepatorenal syndrome.

Authors:  Lise Lotte Gluud; Kurt Christensen; Erik Christensen; Aleksander Krag
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

8.  Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials.

Authors:  Mauro Bernardi; Paolo Caraceni; Roberta J Navickis; Mahlon M Wilkes
Journal:  Hepatology       Date:  2012-04       Impact factor: 17.425

9.  Spectroscopic and thermodynamic determination of three distinct binding sites for Co(II) ions in human serum albumin.

Authors:  Magdalena Sokołowska; Małgorzata Wszelaka-Rylik; Jarosław Poznański; Wojciech Bal
Journal:  J Inorg Biochem       Date:  2009-05-03       Impact factor: 4.155

10.  Cardiovascular complications of cirrhosis.

Authors:  S Møller; J H Henriksen
Journal:  Postgrad Med J       Date:  2009-01       Impact factor: 2.401
View more
  32 in total

1.  Comparison of 5% human albumin and normal saline for fluid resuscitation in sepsis induced hypotension among patients with cirrhosis (FRISC study): a randomized controlled trial.

Authors:  Cyriac Abby Philips; Rakhi Maiwall; Manoj Kumar Sharma; Ankur Jindal; Ashok Kumar Choudhury; Guresh Kumar; Ankit Bhardwaj; Lalita Gouri Mitra; Prashant Mohan Agarwal; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2021-05-25       Impact factor: 6.047

2.  Plasma-derived medicinal products: demand and clinical use.

Authors:  Giuliano Grazzini; Pier Mannuccio Mannucci; Fabrizio Oleari
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

3.  The Roche Immunoturbidimetric Albumin Method on Cobas c 501 Gives Higher Values Than the Abbott and Roche BCP Methods When Analyzing Patient Plasma Samples.

Authors:  Johanna Helmersson-Karlqvist; Mats Flodin; Aleksandra Mandic Havelka; Xiao Yan Xu; Anders Larsson
Journal:  J Clin Lab Anal       Date:  2016-05-12       Impact factor: 2.352

Review 4.  Albumin in chronic liver disease: structure, functions and therapeutic implications.

Authors:  Rosaria Spinella; Rohit Sawhney; Rajiv Jalan
Journal:  Hepatol Int       Date:  2015-09-29       Impact factor: 6.047

5.  The Effect of Stereotactic Injections on Demyelination and Remyelination: a Study in the Cuprizone Model.

Authors:  Laura Salinas Tejedor; Tanja Wostradowski; Stefan Gingele; Thomas Skripuletz; Viktoria Gudi; Martin Stangel
Journal:  J Mol Neurosci       Date:  2017-01-26       Impact factor: 3.444

6.  Development of a textile based protein sensor for monitoring the healing progress of a wound.

Authors:  Yomna ElSaboni; John A Hunt; Jessica Stanley; Christine Moffatt; Yang Wei
Journal:  Sci Rep       Date:  2022-05-13       Impact factor: 4.996

Review 7.  Overview of Albumin Physiology and its Role in Pediatric Diseases.

Authors:  Charles B Chen; Bilasan Hammo; Jessica Barry; Kadakkal Radhakrishnan
Journal:  Curr Gastroenterol Rep       Date:  2021-07-02

8.  Low Serum Albumin Predicts Severe Outcomes in COVID-19 Infection: A Single-Center Retrospective Case-Control Study.

Authors:  Roshan Acharya; Dilli Poudel; Riley Bowers; Aakash Patel; Evan Schultz; Michael Bourgeois; Rishi Paswan; Scott Stockholm; Macelyn Batten; Smita Kafle; Kriti Lonial; Irlene Locklear
Journal:  J Clin Med Res       Date:  2021-05-25

Review 9.  Chemically Modified Biopolymers for the Formation of Biomedical Hydrogels.

Authors:  Victoria G Muir; Jason A Burdick
Journal:  Chem Rev       Date:  2020-12-23       Impact factor: 72.087

10.  Non-mercaptalbumin is significantly associated with the coronary plaque burden and the severity of coronary artery disease.

Authors:  Shengpu Chou; Keiko Yasukawa; Yusuke Fujino; Midori Ishibashi; Mikiko Haraguchi; Masaya Sato; Hitoshi Ikeda; Sunao Nakamura; Yutaka Yatomi
Journal:  Sci Rep       Date:  2021-07-09       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.